CC
CNMD icon

Centiva Capital’s CONMED CNMD Stock Holding History

Centiva Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,530
Closed -$861K – 1200
2025
Q2 		$861K Buy
16,530
+11,600
+235% +$637K 0.01% 684
2025
Q1 		$298K Buy
+4,930
New +$318K 0.01% 1086
2024
Q3 		– Sell
-17,074
Closed -$1.18M – 2203
2024
Q2 		$1.18M Sell
17,074
-4,924
-22% -$359K 0.02% 685
2024
Q1 		$1.76M Buy
21,998
+16,409
+294% +$1.46M 0.04% 385
2023
Q4 		$612K Buy
+5,589
New +$578K 0.01% 855
2023
Q3 		– Sell
-2,052
Closed -$279K – 1759
2023
Q2 		$279K Buy
+2,052
New +$251K 0.01% 1156

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Centiva Capital's CNMD Position: Q3 2025 in Review

Centiva Capital sold out of CONMED (CNMD) in Q3 2025, closing a stake of 16,530 shares — an estimated $861K sold.

Centiva Capital first reported a position in CNMD in Q2 2023 and held it in 6 quarters. The position peaked at $1.76M in Q1 2024. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • Centiva Capital reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 16,530 CONMED shares in Q3 2025, an estimated $861K.
  • Centiva Capital first reported a position in CONMED in Q2 2023 and held it in 6 quarters.
  • Centiva Capital's CONMED position peaked at $1.76M in Q1 2024.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.